Media Update New data presented at ATS demonstrate Sanofi s leadership in advancing potential new therapies for patients with immune-mediated respiratory.
1. Adding chemotherapy to immunotherapy did not prolong OS or PFS, with non-significant differences in HR. 2. Grade 3 or higher immune-related adverse events occurred in 24.3% and 17.9% in the ICI-chemotherapy and ICI-alone groups. Evidence Rating Level: 2 (Good) Study Rundown: Immune checkpoint inhibitors (ICIs) have significantly improved outcomes in non-small cell lung cancer
Grünen-Chef Robert Habeck hat Nicht-Geimpfte mit deutlichen Worten zum Impfen aufgefordert. Zugleich sprach er sich dafür aus, dass Corona-Tests kostenlos bleiben sollten. Aktuelle Corona-News.